Clinical Trials Directory

Trials / Unknown

UnknownNCT03872219

Biodiversity Intervention and Atopic Sensitization

The Effect of Plant and Soil-based Material on the Incidence of Atopic Sensitization

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
350 (estimated)
Sponsor
University of Helsinki · Academic / Other
Sex
All
Age
1 Month
Healthy volunteers
Accepted

Summary

Children will receive biodiversity intervention or placebo. The proof of concept trial is double blind. Intervention will start at the age of 2 months and last 10 months. Children will be randomized to arms. IgE sensitization is the primary outcome.

Detailed description

Newborns will start to be exposed to biodiversity intervention or placebo at the age of two months. The proof of concept trial will be double blind. Intervention will start at the age of 2 months and it will end when children become 12 months old. Children will be randomized to the two arms. IgE sensitization is the primary outcome at the age of two and three years.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTNature-based materialsIn the intervention arm, theycontain inactive and slowly-growing environmental bacteria and other microbiota. In the placebo arm, they do not contain the microbiota.

Timeline

Start date
2019-03-25
Primary completion
2023-08-31
Completion
2025-12-31
First posted
2019-03-13
Last updated
2019-03-13

Source: ClinicalTrials.gov record NCT03872219. Inclusion in this directory is not an endorsement.